Myocardial fibrosis occurs in non-hospitalised patients with chronic symptoms after COVID-19.

Krishnan, A; Ellenberger, K A; Phetsouphanh, C; Kelleher, A P; Matthews, G V; Darley, D R; Holloway, C J

Krishnan, A; Ellenberger, K A; Phetsouphanh, C; Kelleher, A P; Matthews, G V; Darley, D R; Holloway, C J.

Krishnan A; St Vincent's Hospital, Sydney, NSW, Australia.
Ellenberger KA; St Vincent's Hospital, Sydney, NSW, Australia.
Phetsouphanh C; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Kelleher AP; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Matthews GV; St Vincent's Hospital, Sydney, NSW, Australia.
Darley DR; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Holloway CJ; St Vincent's Hospital, Sydney, NSW, Australia.

Int J Cardiol Heart Vasc ; 39: 100964, 2022 Apr.

Article in English | MEDLINE | ID: covidwho-1649973

Keywords

COVID-19; Cardiac function; Cardiovascular magnetic resonance; Myocardial fibrosis; Pulmonary fibrosis

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Int J Cardiol Heart Vasc Year: 2022 Document Type: Article Affiliation country: J.ijcha.2022.100964

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google